CCAAT/enhancer binding protein α (C/EBPα) and C/EBPα myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with nuclear factor-κB p50

Molecular Cancer Research

Volumn 3, Issue 10, 2005, Pages 585-596

  Paz Priel, Ido ^a   Cai, Dong Hong ^a   Wang, Dehua ^a   Kowalski, Jeanne ^a   Blackford, Amanda ^a   Liu, Huaitian ^a   Heckman, Caroline A ^b   Gombart, Adrian F ^c   Koeffler, H Phillip ^c   Boxer, Linda P ^b   Friedman, Alan D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CELL EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 3; LEUCINE ZIPPER PROTEIN; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P50; RNA; SYNAPTOTAGMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CEBPA GENE; CELL PROTECTION; CONTROLLED STUDY; DRUG TARGETING; EMBRYO; GENE; GENE ACTIVATION; GENE INDUCTION; GENE MUTATION; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MALIGNANT TRANSFORMATION; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPLEEN CELL; TRANSGENIC MOUSE;

ADULT; ANIMALS; APOPTOSIS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE; HEMATOPOIETIC STEM CELLS; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NF-KAPPA B P50 SUBUNIT; ONCOGENE PROTEINS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS);

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 27644473283     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-05-0111     Document Type: Article

References (70)

1. Landschulz WH, Johnson PF, McKnight SL. The DNA binding domain of the rat liver protein C/EBP is bipartite. Science 1989;246:1681-8.
2. Friedman AD, McKnight SL. Identification of two polypeptide segments of CCAAT/enhancer-binding protein required for transcriptional activation of the serum albumin gene. Genes Dev 1990;4:1416-26.
3. Birkenmeier EH, Gwyenn B, Howard S, et al. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev 1989;3:1146-56.
4. Li F, Rosenberg E, Smith CI, et al. Correlation of expression of transcription factor C/EBPα and surfactant protein genes in lung cells. Am J Physiol 1995;269:241-7.
5. Roth M, Johnson PRA, Borger P, et al. Dysfunctional interaction of C/EBPα and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N Engl J Med 2004;351:560-74.
6. Williams SC, Cantwell CA, Johnson PF. A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev 1991;5:1553-67.
7. Scott LM, Civin CI, Rorth P, Friedman AD. A novel temporal pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 1992;80:1725-35.
8. Pabst T, Mueller BU, Zhang P, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia. Nat Genet 2001;27:263-70.
9. Gombart AF, Hofmann WK, Kawano S, et al. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemias. Blood 2002;99:1332-40.
10. Cleaves R, Wang QF, Friedman AD. C/EBPαp30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding. Oncogene 2004;23:716-25.
11. Preudhomme C, Sagot C, Boissel N, et al. Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). Blood 2002;100:2717-23.
12. Frohling S, Schlenk RF, Stolze I, et al. CEBPA mutations in young adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol 2004;22:624-33.
13. Pabst T, Mueller BU, Harakawa N, et al. AML1-ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia. Nat Med 2001;7:444-51.
14. Zheng R, Friedman AD, Levis M, Li L, Weir EG, Small D. Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPα expression. Blood 2004;103:1883-90.
15. Perrotti D, Cesi V, Trotta R, et al. Bcr-abl suppresses C/EBPα expression through inhibitory action of hnRNP E2. Nat Genet 2002;30:48-58.
16. Oelgeschläger M, Nuchprayoon I, Lüscher B, Friedman AD. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol Cell Biol 1996;16:4717-25.
17. Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG. PU.1 (Spi-1) and C/EBPα regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 1996;88:1234-47.
18. Umek RM, Friedman AD, McKnight SL. CCAAT-enhancer binding protein: a component of a differentiation switch. Science 1991;251:288-92.
19. Cram EJ, Ramos RA, Wang EC, Cha H, Nishio Y, Firestone GL. Role of the CCAAT/enhancer binding protein-α transcription factor in the glucocorticoid stimulation of p21waf1/cip1 gene promoter activity in growth-arrested rat hepatoma cells. J Biol Chem 1998;273:2008-14.
20. Wang H, Iakova P, Wilde M, et al. C/EBPα arrests cell proliferation through direct inhibition of cdk2 and cdk4. Mol Cell 2001;8:817-28.
21. Porse BT, Pedersen TA, Xu X, et al. E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo. Cell 2001;107:247-58.
22. Muller C, Calkhoven CF, Sha X, Leutz A. The CCAAT enhancer-binding protein α (C/EBPα) requires a SW1/SNF complex for proliferation arrest. J Biol Chem 2004;279:7353-8.
23. Catz SD, Johnson JL. Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer. Oncogene 2001;20:7342-51.
24. Heckman CA, Mehew JW, Boxer LM. NF-κB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene 2002;21:3898-908.
25. Heckman CA, Wheeler MA, Boxer LM. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells. Oncogene 2003;22:7891-9.
26. Stein B, Cogswell PC, Baldwin AS, Jr. Functional and physical associations between NF-κB and C/EBP family members: a Rel domain-bZIP interaction. Mol Cell Biol 1993;13:3964-74.
27. Guzman ML, Neering SJ, Upchurch D, et al. Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 2001;98:2301-7.
28. Burgess-Beusse BL, Darlington GJ. C/EBPα is critical for neonatal acute-phase response to inflammation. Mol Cell Biol 1998;18:7269-77.
29. Bullinger L, Dohner K, Bair E, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004;350:1605-28.
30. Valk PJM, Verhaak RGW, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004;350:1617-28.
31. Banker DE, Radich J, Becker A, et al. The t(8;21) translocation is not consistently associated with high bcl-2 expression in de novo acute myeloid leukemia of adults. Clin Cancer Res 1998;4:3051-62.
32. Nunez G, London I, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hematopoietic cell lines. J Immunol 1990;144:3602-10.
33. Wang X, Scott E, Sawyers CL, Friedman AD. C/EBPα by-passes G-CSF signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32Dcl3 myeloblasts. Blood 1999;94:560-71.
34. Canman CE, Gilmer TM, Coutts SB, Kastan MB. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 1995;9:600-11.
35. Johnson BW, Cepero E, Boise LH. Bcl-xL inhibits cytochrome c release but not mitochondrial depolarization during the activation of multiple death pathways by tumor necrosis factor-α. J Biol Chem 2000;275:31546-53.
36. Bouillet P, Metcalf D, Huang DC, et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999;286:1735-8.
37. Wessells J, Yakar S, Johnson PF. Critical prosurvival roles for C/EBPβ and insulin-like growth factor I in macrophage tumor cells. Mol Cell Biol 2004;24:3238-50.
38. Britos-Bray M, Ramirez M, Cao W, et al. CBFβ-SMMHC, expressed in M4eo acute myeloid leukemia, reduces p53 induction and slows apoptosis in hematopoietic cells exposed to DNA-damaging agents. Blood 1998;92:4344-52.
39. Agre P, Johnson PF, McKnight SL. Cognate DNA binding specificity retained after leucine zipper exchange between GCN4 and C/EBP. Science 1989;246:922-6.
40. Miller M, Shuman JD, Sebastian T, Dauter Z, Johnson PF. Structural basis for DNA recognition by the basic region leucine zipper transcription factor CCAAT/enhancer-binding protein α. J Biol Chem 2003;278:15178-84.
41. Friedman AD. Transcriptional control of granulocyte and monocyte development. Oncogene 2001;21:3377-90.
42. Zhang P, Iwasaki-Arai J, Iwasaki H, et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα. Immunity 2004;21:853-63.
43. LeClair K, Blanar MA, Sharp PA. The p50 subunit of NF-κB associates with the NF-IL6 transcription factor. Proc Natl Acad Sci U S A 1992;89:8145-9.
44. Matsusaka T, Fujikawa K, Nishio Y, et al. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A 1993;90:10193-7.
45. Kunsch C, Lang RK, Rosen CA, Shannon MF. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. J Immunol 1994;153:153-64.
46. Dunn SM, Coles LS, Lang RK, Gerondakis S, Vadas MA, Shannon MF. Requirement for nuclear factor (NF)-κB p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood 1994;83:2469-79.
47. Ray A, Hannink M, Ray BK. Concerted participation of NF-κB and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver. J Biol Chem 1995;270:7365-74.
48. Xia C, Cheshire JK, Patel H, Woo P. Cross-talk between transcription factors NF-κB and C/EBP in the transcriptional regulation of genes. Int J Biochem Cell Biol 1997;29:1525-39.
49. Catron KM, Brickwood JR, Shang C, Li Y, Shannon MF, Parks TP. Cooperative binding and synergistic activation by RelA and C/EBPβ on the intercellular adhesion molecule-1 promoter. Cell Growth Differ 1998;9:949-59.
50. Maehara K, Hasegawa T, Xiao H, Takeuchi A, Abe R, Isobe K. Cooperative interaction of NF-κB and C/EBP binding sites is necessary for manganese superoxide dismutase gene transcription mediated by lipopolysaccharide and interferon-γ. FEBS Lett 1999;449:115-9.
51. Papin S, Cazeneuve C, Duquesnoy P, Jeru I, Sahali D, Amselem S. The tumor necrosis factor α-dependent activation of the human Mediterranean fever (MEFV) promoter is mediated by a synergistic interaction between C/EBPβ and NF κB p65. J Biol Chem 2003;278:48839-47.
52. Ondrey FG, Dong G, Sunwoo J, et al. Constitutive activation of transcription factors NF-κB, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and proangiogenic cytokines. Mol Carcinog 1999;26:119-29.
53. Xiao W, Hodge DR, Wang L, Yang X, Zhang X, Farrar WL. Co-operative functions between nuclear factors NF-κB and CCAAT/enhancer-binding protein-β (C/EBP-β) regulate the IL-6 promoter in autocrine human prostate cancer cells. Prostate 2004;61:354-70.
54. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression. Cancer Cell 2004;6:297-305.
55. Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-6.
56. Greten FR, Eckmann L, Greten TF, et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;118:285-96.
57. Guzman ML, Swiderski CF, Howard DS, et al. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci U S A 2002;99:16220-5.
58. Kurland JF, Kodym R, Story MD, Spurgers KB, McDonnell TJ, Meyn RE. NF-κB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene. J Biol Chem 2001;276:45380-6.
59. Hoffmann A, Leung TH, Baltimore D. Genetic analysis of NF-κB/Rel transcription factors defines functional specificities. EMBO J 2003;22:5530-9.
60. Phelps CM, Sengchanthalangsy LL, Huxford T, Ghosh G. Mechanism of IκBα binding to NF-κB dimers. J Biol Chem 2000;275:29840-6.
61. Palacios R, Steinmetz M. IL3-dependent mouse clones that express B-220 and surface antigen, contain Ig genes in germ-line configuration, and generate dysplastic hematopoietic progenitors. Blood 1985;91:3134-43.
62. Valtieri M, Tweardy DJ, Caracciolo D, et al. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol 1987;138:3829-35.
63. Calvo KR, Sykes DB, Pasillas M, Kamps MP. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Mol Cell Biol 2000;20:3274-85.
64. Collins SJ, Ulmer J, Purton LE, Darlington G. Multipotent hematopoietic cell lines derived from C/EBPα(-/-) knockout mice display granulocyte macrophage-colony stimulating factor, granulocyte-colony stimulating factor, and retinoic acid-induced granulocytic differentiation. Blood 2001;98:2382-8.
65. Finer MH, Dull TJ, Qin L, Farson D, Roberts MR. Kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 1994;83:43-50.
66. Wang Q, Cleaves R, Kummalue T, Nerlov C, Friedman AD. Cell cycle inhibition mediated by the outer surface of the C/EBPα basic region is required but not sufficient for granulopoiesis. Oncogene 2003;22:2548-57.
67. Wang Q, Friedman AD. C/EBPs are required for granulopoiesis independent of their induction of the granulocyte-colony stimulating factor receptor. Blood 2002;99:2776-85.
68. Heckman CA, Mehew JW, Ying GG, Introna M, Golay J, Boxer LM. A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells. J Biol Chem 2000;275:6499-508.
69. Pircher H, Mak TW, Lang R, et al. T cell tolerance to Mlsa encoded antigens in T cell receptor Vβ 8.1 chain transgenic mice. EMBO J 1989;8:719-27.
70. Hall P. The bootstrap and edgeworth expansion. New York; Springer-Verlag; 1992. p. 1-35.